This paper appears in the following:
- Trials and Tribulations—Autopsy Reveals Pros and Cons of AD Vaccine
- Sorrento: Immunotherapy Update Hot Off Lectern of AD/PD Conference
- Madrid: News from the Vaccine Front—Phase 2 Postmortem, Part 1
- PIB-PET Biomarker Study Confirms Bapineuzumab Lowers Amyloid
- AD Immunotherapy: Toward Prevention, DNA-based Vaccines?
- Research Brief: Is Rare Amyloid Disorder Autoimmune Disease?